Overview

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

Status:
Completed
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
Phase:
Phase 2
Details
Lead Sponsor:
Sirion Therapeutics, Inc.
Treatments:
Difluprednate
Fluprednisolone